Quantum BioPharma is trading 10.34% down now at $3.21 as broader risk-off sentiment weighs on equities.
- The S&P 500, Nasdaq Composite, and Dow Jones are each down more than 0.5%.
- Hotter producer inflation and oil above $100 are keeping bond yields elevated and rate-cut expectations muted.
- No new company-specific announcement was identified on September 10, 2026; the latest catalyst was FDA clearance for Lucid-MS trials.